COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,756 Articles (22,502 medRxiv, 8,254 bioRxiv)

Most recent first Previous |  Page 1483: Articles 14821-14830  | Next

In hospital cardiac arrest in Intensive Care Unit versus non Intensive Care Unit patients with COVID 19. A systematic review and meta analysis
Mavrovounis, G., Mermiri, M., Chalkias, A., Sheth, V., Tsolaki, V., Gourgoulianis, K., Pantazopoulos, I.
10.1101/2021.05.08.21256885 — Posted: 2021-05-14
Evolution of human antibody responses up to one year after SARS-CoV-2 infection
Gallais, F., Gantner, P., Bruel, T., Velay, A., Planas, D., Wendling, M.-J., Bayer, S., Solis, M., Laugel, E., Reix, N., Schneider, A., Glady, L., Panaget, B., Collongues, N., Partisani, M., Lessinger, J.-M., Fontanet, A., Rey, D., Hansmann, Y., Kling-Pillitteri, L., Schwartz, O., De Seze, J., Meyer, N., Gonzalez, M., Schmidt-Mutter, C., Fafi-Kremer, S.
10.1101/2021.05.07.21256823 — Posted: 2021-05-14
Immune Responses to COVID-19 mRNA Vaccines in Patients with Solid Tumors on Active, Immunosuppressive Cancer Therapy
Shroff, R. T., Chalasani, P., Wei, R., Pennington, D., Quirk, G., Schoenle, M. V., Uhrlaub, J. L., Ripperger, T. J., Jergovic, M., Dalgai, S., Wolf, A., Hammad, H., Carrier, A., Scott, A. J., Nikolich-Zugich, J., Worobey, M., Sprissler, R., Dake, M. D., LaFleur, B. J., Bhattacharya, D.
10.1101/2021.05.13.21257129 — Posted: 2021-05-14 Discussion: Onsite
Post-acute COVID-19 syndrome and its prolonged effects: An updated systematic review
Malik, J., Zaidi, S. M. J., Ishaq, U., Ali, M., Rana, A. S., Iqbal, R., Waqar, A. U., Kashif, M.
10.1101/2021.05.09.21256911 — Posted: 2021-05-14
Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variant
Knabl, L., Lee, H. K., Wieser, M., Mur, A., Zabernigg, A., Knabl, L., Rauch, S., Bock, M., Schumacher, J., Kaiser, N., Furth, P. A., Hennighausen, L.
10.1101/2021.05.11.21256862 — Posted: 2021-05-14
COVID-19 case definitions, diagnostic testing criteria, and surveillance across the pandemic's 25 highest burden countries
Suthar, A., Schubert, S., Garon, J., Couture, A., Brown, A., Charania, S.
10.1101/2021.05.11.21257047 — Posted: 2021-05-14
Cellular immunity predominates over humoral immunity after the first dose of COVID-19 vaccines in solid organ transplant recipients
Schmidt, T., Klemis, V., Schub, D., Schneitler, S., Reichert, M. C., Wilkens, H., Sester, U., Sester, M., Mihm, J.
10.1101/2021.05.07.21256809 — Posted: 2021-05-14
Acute biliary pancreatitis management during the COVID-19 pandemic
Colak, E., Ciftci, A. B.
10.1101/2021.05.08.21256726 — Posted: 2021-05-14
Different approaches to quantify years of life lost from COVID-19
Ferenci, T.
10.1101/2021.05.13.21257193 — Posted: 2021-05-14
SARS-CoV-2 naïve and recovered individuals show qualitatively different antibody responses following mRNA vaccination
Tejedor Vaquero, S., de Campos-Mata, L., Ramada, J. M., Diaz, P., Navarro-Barriuso, J., Ribas-Llaurado, C., Rodrigo Melero, N., Carolis, C., Cerutti, A., Gimeno, R., Magri, G.
10.1101/2021.05.07.21256821 — Posted: 2021-05-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).